BIOKA — Biokarpet Industrial and Commercial Enterprises SA Income Statement
0.000.00%
Last trade - 00:00
- €65.72m
- €156.55m
- €231.22m
- 33
- 71
- 33
- 40
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 119 | 126 | 123 | 187 | 231 |
Cost of Revenue | |||||
Gross Profit | 22.3 | 25.1 | 23.7 | 31.5 | 41.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 117 | 121 | 119 | 179 | 216 |
Operating Profit | 2.9 | 4.57 | 4.05 | 8.54 | 14.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.269 | 1.96 | 0.734 | 5.02 | 10.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.193 | 1.27 | 0.22 | 4.26 | 9.13 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.171 | 1.24 | 0.203 | 4.21 | 8.99 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.171 | 1.24 | 0.203 | 4.21 | 8.99 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | 0.058 | 0.022 | 0.205 | 0.329 |
Dividends per Share | |||||
Special Dividends per Share |